SRC and neoplasm: For example, the Src inhibitor dasatinib inhibits TNBC cell growth in vitro, inhibits TNBC tumor growth in animal models, and inhibits TNBC tumor growth in TNBC patients, resulting in stable disease in a significant portion of patients.